- Joined
- Jul 31, 2006
- Messages
- 96
- Reaction score
- 1
I know this is probably like beating a dead horse, but we still have levalbuterol on our formulary.
I have found several articles comparing the two, but most of the studies are very small and involve pediatric asthma patients and these usually show a small benefit in levalbuterol. There was also a recent study in CHEST and a small study in AJHP done in 2003 that didn't show a difference in ADRs in critically ill patients (which is along the lines of what I'm looking for). We have several cardio surgeons that swear by levalbuterol for their patients and that is why it is still on our formulary.
I was wondering if anyone had a formal P&T monograph for an autosub to albuterol. All I want are your references to see if there is something major I am not finding.
Thanks in advance.
I have found several articles comparing the two, but most of the studies are very small and involve pediatric asthma patients and these usually show a small benefit in levalbuterol. There was also a recent study in CHEST and a small study in AJHP done in 2003 that didn't show a difference in ADRs in critically ill patients (which is along the lines of what I'm looking for). We have several cardio surgeons that swear by levalbuterol for their patients and that is why it is still on our formulary.
I was wondering if anyone had a formal P&T monograph for an autosub to albuterol. All I want are your references to see if there is something major I am not finding.
Thanks in advance.